Kyriakos Kansos

Partner Fuliginous Management Consulting

Workshop Day - Tuesday 9 March 2027

1:30 PM WORKSHOP A: BEYOND THE ORIGINAL AGREEMENT: A PRACTICAL FRAMEWORK FOR CDMO REPRICING

There is no standard approach to repricing an external manufacturing agreement. Each situation is influenced by product complexity, manufacturing volumes, available capacity, alternative supply options, service requirements, and the strategic importance of the partnership. Although repricing ultimately concerns the manufacturing unit price, it is influenced by multiple underlying factors, including labour, energy, materials, quality activities, logistics, capacity utilisation, and investment requirements. At the same time, pharmaceutical companies must maintain budget predictability, product competitiveness, and supply continuity.

Repricing may occur through a scheduled annual review or become necessary during the contract term following significant changes in costs, volumes, product requirements, or service scope. The key question is therefore not simply whether prices should change, but how any adjustment can be justified, assessed, negotiated, and implemented fairly.

In this interactive workshop, participants will examine repricing from both the pharmaceutical company and CDMO perspectives. Practical scenarios and structured frameworks will be used to explore how companies can build and evaluate a robust repricing case, distinguish justified cost changes from commercial repositioning, and identify alternatives to a straightforward unit-price increase. The workshop will be facilitated by Fuliginous Management Consulting, drawing on its team's extensive, hands-on experience in CDMO costing, pricing, profitability measurement, industry best practices, and pharma–CDMO negotiations.

Join this workshop to:

• Determine when repricing is justified and what supporting evidence should be provided.

• Build and assess a transparent, fact-based repricing case.

• Explore alternatives to direct unit-price increases, including volume commitments, operational improvements, scope changes, and risk-sharing mechanisms.

• Design effective contractual price-review mechanisms, including indices, thresholds, formulas, and governance processes

Conference Day One - Wednesday 10 March 2027

4:45 PM KEYNOTE: FINDING THE RIGHT CDMO: A DATA-DRIVEN APPROACH TO PARTNER IDENTIFICATION

Identifying the right CDMO for a specific product is increasingly complex. Manufacturing technology is only the starting point: dosage form, process requirements, containment level, batch size, regulatory approvals, geographic footprint, available capacity and strategic fit can all determine whether a CDMO is technically suitable.

During this 30-minute presentation, Fuliginous Management Consulting will demonstrate how its proprietary web-based intelligence platform can transform the initial CDMO search from a process lasting weeks—or even months—into one completed within minutes. Covering more than 780 CDMOs, 1,480 manufacturing sites of finished dosage forms and 35 manufacturing technologies, the platform systematically screens the market and narrows an extensive universe of manufacturers to the most relevant candidates for a specific product.

Participants will learn how combining detailed manufacturing data with practical CDMO market expertise can:

• Identify CDMO facilities with the required technologies and capabilities .

• Evaluate product–site fit beyond generally stated capabilities.

• Reduce initial market screening from weeks or months to minutes.

• Uncover suitable partners that may be missed through conventional searches.

5:15 PM PANEL DISCUSSION: DELEGATE VOICES, ADVISORY BOARD INSIGHTS

Ahead of the conference, we launched a delegate survey to gather insights on what participants hoped to gain from the three-day event, as well as the key challenges currently facing pharma contract manufacturing. The survey explored critical topics such as supply chain disruptions, the impact of geopolitical tensions, and the ongoing debate between localisation and centralisation.

In this session, our Advisory Board will review the survey findings, address delegates' most pressing concerns, and facilitate an open discussion on the issues that matter most to those in the room.

Check out the incredible speaker line-up to see who will be joining Kyriakos.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: +44 (0) 113 210 042
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk